Posted by Michael Wonder on 26 Jul 2024
EMA publishes agenda for 22-25 July 2024 CHMP meeting
22 July 2024 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Delgocitinib
- Axitinib
- Ustekinumab
- Trastuzumab
- Elafibranor
- Rituximab
- Odevixibat sesquihydrate
- Lecanemab
- Toripalimab
- Ranibizumab
- Cyclosporin
- Zolbetuximab
- Macitentan with tadalafil
